As reported by Medscape Medical News, earlier this month the ... Within a week of the FDA's decision, Lykos announced it was cutting its staff by 75% and that Rick Doblin, PhD, the founder and ...
“You never know what the news is, but my dad opened his eyes ... But at this early stage, the Food and Drug Administration has only approved xenotransplants for patients on the verge of death ...
This story is part of a special series celebrating the 10th anniversary of the Fast Company Innovation Festival. When ...
OAT refers to treatment services that use FDA-approved opioid medications ... virtually every measure—and have also been proven to cut the risk of overdose deaths in half," Carroll says.
The FDA and manufacturers routinely allow doctors and hospitals to continue using medical devices that could cause serious ...
The Food and Drug Administration on Thursday approved Apple's new "Hearing Aid Feature" which will amplify sounds for people with perceived mild to moderate hearing impairment. The Apple feature ...
Alesi Surgical designed the Ultravision2 IonPencil for cutting and coagulating soft tissue in open surgery while managing ...
The Food and Drug Administration said on Thursday it has approved a piece of software that will transform the latest model of Apple’s AirPods Pro earbuds into over-the-counter hearing aids.
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.
FDA & Palatin agree on clear regulatory path for PL9643 NDA submission in DED FDA confirms acceptability of protocols and endpoints for remaining MELODY-2 & MELODY-3 Phase 3 Pivotal Clinical ...
There's more bad news for the company behind an experimental MDMA therapy for post-traumatic stress disorder, which the Food and Drug Administration roundly rejected earlier this month.
The Food and Drug Administration is ramping up its investigation ... Lykos said it would cut 75% of its staff but that it would try to resubmit its application for the drug therapy.